Developing a predictive score for complications after ERCP procedures
Official title: Studio Osservazionale Per lo Sviluppo di Uno Score Predittivo Degli Eventi Avversi Post-colangiopancreatografia Retrograda Endoscopica (ERCP)
Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06776874 · Data updated 2026-11-12
This study is trying to find out what factors can lead to complications after ERCP procedures to help predict risks for patients undergoing this treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 981 (estimated) |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna) |
| Status | Recruiting |
| Started | March 24, 2021 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | January 15, 2025 |
| Trial ID | NCT06776874 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old with hepato-biliary-pancreatic diseases requiring ERCP treatment.
✕Probably not a fit
Patients who do not require ERCP or are under 18 years old may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify independent factors that increase the risk of complications following endoscopic retrograde cholangiopancreatography (ERCP). It will develop and validate a predictive model for adverse events based on data collected from patients undergoing ERCP. The study also seeks to evaluate the rate of post-ERCP complications across participating centers, addressing limitations in previous research regarding risk factor identification and complication rates.
Why it matters
Potential benefit: If successful, this study could lead to improved risk assessment and prevention strategies for patients undergoing ERCP, potentially reducing the incidence of adverse events.
How similar studies have gone: Previous studies have attempted to identify risk factors for ERCP complications, but this study aims to provide a more precise and validated predictive model, making it a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>18 years * Patients admitted with hepato-biliary-pancreatic disease or other pathological conditions that require treatment by ERCP * Obtaining informed consent Exclusion Criteria: * None
Where it's running
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy Recruiting
Study contacts
- Principal investigator: Lorenzo Lorenzo, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Lorenzo Fuccio, MD
- Email: lorenzo.fuccio@aosp.bo.it
- Phone: 0512143338
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HFNC vs Microstream nasal cannula during ERCP
This study compares high-flow nasal oxygen with the Microstream Advance nasal cannula to see which one better keeps patients’ oxygen levels stable during ERCP procedures done under deep sedation.
-
Using biodegradable stents to treat bile duct issues in liver transplant patients
This study is testing if biodegradable stents can help liver transplant patients with bile duct problems feel better and avoid complications compared to regular plastic stents.
-
Using a pancreatic stent to reduce pancreatitis risk after a specific procedure
This study tests if putting a stent in the pancreas can help prevent pancreatitis in patients who have a tough time with a certain procedure called ERCP.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.